CARLSBAD, Calif.--(BUSINESS WIRE)--GenMark Diagnostics, Inc. (NASDAQ: GNMK), a provider of automated, multiplex molecular diagnostic testing systems, announced today that Dr. James (Jim) Fox has been appointed to GenMark’s Board of Directors. Dr. Fox will Chair GenMark’s compensation committee and also sit on the audit and corporate governance and nominating committees.
